Prostate Drug Might Boost Heart Risks (HealthDay)The commonly prescribed prostate drug doxazosin may increase heart failure risk by blocking specific receptors in heart muscle cells, an animal study suggests.

Genetic Screening Model Identifies Colon Cancer Risk (HealthDay)Scottish researchers say they’ve developed a method that can better identify people at risk of certain types of hereditary colon cancer, as well as help guide treatment choices for those already diagnosed with colon cancer.

Moms, Dads Worry as Summer Season Begins (HealthDay)Spanish ID:532973–>

Key Factors Spur Older Cancer Patients to Quit Chemo (HealthDay)Physical weakness, treatment complications, and a lack of social and psychological support can keep elderly patients with stage III colon cancer from finishing chemotherapy after surgery, a new U.S. study finds.

FDA Approves New Combination Therapy for Cervical Cancer (American Cancer Society)Summary: The US Food and Drug Administration has approved the use of topotecan (Hycamtin) along with cisplatin for the treatment of women who have very advanced cervical cancer. The decision was based on a randomized, multi-center trial that found treatment with these 2 drugs is better than treatment with cisplatin alone.

Health Tip: Examining Yourself for Skin Cancer (HealthDay)One of the best protections again skin cancer is to examine your skin regularly. Here are some tips on what to look for, courtesy of the Skin Cancer Foundation:

Posted by webmdalert in Cancer